MBT may fulfill different symptom management needs at varying stages of survivorship. Reasons for and outcomes of MBT use varied among the survivorship stages, with more acute survivors reporting medical-related reasons and more short-term survivors reporting to manage symptoms. In the adjusted model, short-term survivors had 35 % greater odds of MBT use than did controls (95 % CI 1.00, 1.83). MBT use varied by cancer survivorship stage ( p = 0.02): acute (8.3 %), short-term (15.4 %), long-term (11.7 %) survivorship and non-cancer controls (13.2 %). Weighted percentages were calculated by survivorship stage for reported reasons and outcomes of use and frequency of MBT types. Logistic regression tested the relationship of MBT use and survivorship stage. The sample included cancer survivors ( N = 3076) and non-cancer controls ( N = 31,387). We also examined reported reasons for and outcomes of MBT use and frequency of MBT types. We examined the relationship between MBT use and survivorship stage (acute 5 years since diagnosis) using the CAM supplement of the 2012 National Health Interview Survey. MBT use may differ by cancer survivorship stage (i.e., acute, short-term, long-term) because each stage presents varying intensities of medical activities, associated emotions, and treatment effects. Mind-body therapies (MBTs), a subset of complementary and alternative medicine (CAM), are used by cancer survivors to manage symptoms related to their cancer experience.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |